Dr. Steven C. Cramer Presents Stem Cell Therapeutics Corp.'s Final Phase IIa BETAS Safety Trial Results (Marketwire via Yahoo! Finance)
Stem Cell Therapeutics Corp. is pleased to announce a presentation of the complete positive results of the Phase IIa BETAS trial conducted by Drs. Steven Cramer, Michael Hill and David Brown at the International Stroke Conference, February 19, 2009 in San Diego, CA.
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Publication of …
Stem Cell Therapeutics Corp. Announces Presentation of Modified REGENESIS Trial Results at the Inter
Stem Cell Therapeutics Corp. Announces Presentation of Modified REGENESIS Trial Results at the International Stroke …